HK Stock MarketDetailed Quotes

01419 HUMAN HEALTH

Watchlist
  • 0.800
  • +0.020+2.56%
Market Closed Dec 2 16:08 CST
303.64MMarket Cap12.50P/E (TTM)

HUMAN HEALTH Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(Q9)Mar 31, 2024
(Q6)Dec 31, 2023
(Q3)Sep 30, 2023
(FY)Jun 30, 2023
(Q6)Dec 31, 2022
(FY)Jun 30, 2022
(Q6)Dec 31, 2021
(FY)Jun 30, 2021
(Q6)Dec 31, 2020
Turnover
-41.02%590.82M
--440.7M
-56.67%295.19M
--141.2M
-10.70%1B
75.34%681.27M
71.34%1.12B
68.45%388.54M
44.29%654.71M
-9.47%230.66M
Operating income
-41.02%590.82M
-56.67%295.19M
-10.70%1B
75.34%681.27M
71.34%1.12B
68.45%388.54M
44.29%654.71M
-9.47%230.66M
Cost of sales
21.43%-320.97M
----
27.53%-154.68M
----
11.60%-408.51M
-23.34%-213.43M
-66.21%-462.11M
-42.20%-173.05M
-5.35%-278.02M
11.34%-121.7M
Operating expenses
21.43%-320.97M
27.53%-154.68M
11.60%-408.51M
-23.34%-213.43M
-66.21%-462.11M
-42.20%-173.05M
-5.35%-278.02M
11.34%-121.7M
Gross profit
-54.51%269.85M
-69.97%140.51M
-10.07%593.24M
117.10%467.84M
75.13%659.69M
97.76%215.5M
98.43%376.69M
-7.29%108.97M
Administrative expenses
24.12%-264.02M
----
10.76%-122.02M
----
-43.89%-347.96M
-27.02%-136.73M
-4.86%-241.83M
4.26%-107.64M
-10.65%-230.63M
-1.06%-112.43M
Operating interest expense
----
----
-3.36%-4.28M
----
----
-276.68%-4.14M
-0.07%-2.93M
36.27%-1.1M
37.52%-2.93M
30.75%-1.72M
Special items of operating profit
793.09%30.22M
----
1,576.34%10.48M
----
-89.53%3.38M
-138.25%-710K
30.86%32.32M
-92.06%1.86M
349.15%24.7M
2,549.66%23.37M
Operating profit
-85.50%36.06M
-92.43%24.69M
-44.40%248.66M
200.39%326.27M
166.48%447.24M
497.34%108.61M
543.19%167.83M
288.77%18.18M
Financing cost
0.93%-8.22M
----
----
----
---8.3M
----
----
----
----
----
Share of profits of associates
17.63%-1.27M
----
35.32%-760K
----
21.95%-1.54M
-202.84%-1.18M
-299.70%-1.98M
-455.96%-388K
186.61%990K
--109K
Earning before tax
-88.88%26.56M
-92.64%23.93M
-46.37%238.82M
200.38%325.09M
163.75%445.26M
491.66%108.23M
532.74%168.82M
382.00%18.29M
Tax
95.90%-2.38M
----
93.15%-3.9M
----
17.12%-57.98M
-220.15%-56.98M
-187.08%-69.95M
-1,173.10%-17.8M
-1,689.06%-24.37M
-114.75%-1.4M
After-tax profit from continuing operations
-86.62%24.19M
-92.53%20.03M
-51.82%180.84M
196.49%268.11M
159.81%375.31M
435.27%90.43M
457.79%144.45M
437.34%16.89M
Earning after tax
-86.62%24.19M
-92.53%20.03M
-51.82%180.84M
196.49%268.11M
159.81%375.31M
435.27%90.43M
457.79%144.45M
437.34%16.89M
Profit attributable to shareholders
-86.62%24.19M
-92.53%20.03M
-51.82%180.84M
196.49%268.11M
159.81%375.31M
435.27%90.43M
457.79%144.45M
437.34%16.89M
Basic earnings per share
-86.55%0.064
-92.49%0.053
-51.87%0.476
196.64%0.706
159.58%0.989
428.89%0.238
459.43%0.381
462.50%0.045
Diluted earnings per share
-86.55%0.064
-92.49%0.053
-51.87%0.476
196.64%0.706
159.58%0.989
428.89%0.238
459.43%0.381
462.50%0.045
Currency Unit
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
--
--
Unaudited opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
Ernst & Young
--
--
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
(FY)Jun 30, 2024(Q9)Mar 31, 2024(Q6)Dec 31, 2023(Q3)Sep 30, 2023(FY)Jun 30, 2023(Q6)Dec 31, 2022(FY)Jun 30, 2022(Q6)Dec 31, 2021(FY)Jun 30, 2021(Q6)Dec 31, 2020
Turnover -41.02%590.82M--440.7M-56.67%295.19M--141.2M-10.70%1B75.34%681.27M71.34%1.12B68.45%388.54M44.29%654.71M-9.47%230.66M
Operating income -41.02%590.82M-56.67%295.19M-10.70%1B75.34%681.27M71.34%1.12B68.45%388.54M44.29%654.71M-9.47%230.66M
Cost of sales 21.43%-320.97M----27.53%-154.68M----11.60%-408.51M-23.34%-213.43M-66.21%-462.11M-42.20%-173.05M-5.35%-278.02M11.34%-121.7M
Operating expenses 21.43%-320.97M27.53%-154.68M11.60%-408.51M-23.34%-213.43M-66.21%-462.11M-42.20%-173.05M-5.35%-278.02M11.34%-121.7M
Gross profit -54.51%269.85M-69.97%140.51M-10.07%593.24M117.10%467.84M75.13%659.69M97.76%215.5M98.43%376.69M-7.29%108.97M
Administrative expenses 24.12%-264.02M----10.76%-122.02M-----43.89%-347.96M-27.02%-136.73M-4.86%-241.83M4.26%-107.64M-10.65%-230.63M-1.06%-112.43M
Operating interest expense ---------3.36%-4.28M---------276.68%-4.14M-0.07%-2.93M36.27%-1.1M37.52%-2.93M30.75%-1.72M
Special items of operating profit 793.09%30.22M----1,576.34%10.48M-----89.53%3.38M-138.25%-710K30.86%32.32M-92.06%1.86M349.15%24.7M2,549.66%23.37M
Operating profit -85.50%36.06M-92.43%24.69M-44.40%248.66M200.39%326.27M166.48%447.24M497.34%108.61M543.19%167.83M288.77%18.18M
Financing cost 0.93%-8.22M---------------8.3M--------------------
Share of profits of associates 17.63%-1.27M----35.32%-760K----21.95%-1.54M-202.84%-1.18M-299.70%-1.98M-455.96%-388K186.61%990K--109K
Earning before tax -88.88%26.56M-92.64%23.93M-46.37%238.82M200.38%325.09M163.75%445.26M491.66%108.23M532.74%168.82M382.00%18.29M
Tax 95.90%-2.38M----93.15%-3.9M----17.12%-57.98M-220.15%-56.98M-187.08%-69.95M-1,173.10%-17.8M-1,689.06%-24.37M-114.75%-1.4M
After-tax profit from continuing operations -86.62%24.19M-92.53%20.03M-51.82%180.84M196.49%268.11M159.81%375.31M435.27%90.43M457.79%144.45M437.34%16.89M
Earning after tax -86.62%24.19M-92.53%20.03M-51.82%180.84M196.49%268.11M159.81%375.31M435.27%90.43M457.79%144.45M437.34%16.89M
Profit attributable to shareholders -86.62%24.19M-92.53%20.03M-51.82%180.84M196.49%268.11M159.81%375.31M435.27%90.43M457.79%144.45M437.34%16.89M
Basic earnings per share -86.55%0.064-92.49%0.053-51.87%0.476196.64%0.706159.58%0.989428.89%0.238459.43%0.381462.50%0.045
Diluted earnings per share -86.55%0.064-92.49%0.053-51.87%0.476196.64%0.706159.58%0.989428.89%0.238459.43%0.381462.50%0.045
Currency Unit HKDHKDHKDHKDHKDHKDHKDHKDHKDHKD
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion------Unaudited opinion--Unqualified Opinion--Unqualified Opinion--
Auditor Ernst & Young------Ernst & Young--Ernst & Young--Ernst & Young--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data